Market Scope

Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis

Choose Your Experience

Over 500 Clients, Large & Small from Around the World, Have Trusted Market Scope Data & Analysis

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

3/22/2024
BreakingEuropeRegulationRetina
Ophthalmic Bevacizumab Candidate from Outlook Gains Positive CHMP Opinion
Ophthalmic Bevacizumab Candidate from Outlook Gains Positive CHMP Opinion

Outlook Therapeutics announced March 22 that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion recommending approval of ONS-5010 (L...

3/22/2024
BreakingDealsDry EyePharmaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Harrow, Alimera Sciences, and EyePoint
2023 Ophthalmic Revenue Roundup for Harrow, Alimera Sciences, and EyePoint

Nashville, Tennessee-based Harrow reported March 19 that its 2023 revenue was $130.2 million, a 47 percent increase over $88.6 million in 2022. The company generated record quarterly revenue in Q4-...

3/22/2024
BreakingClinical TrialRetina
OcuTerra’s Eye Drop Candidate for DR Misses Endpoints in Phase II
OcuTerra’s Eye Drop Candidate for DR Misses Endpoints in Phase II

OcuTerra Therapeutics announced March 14 that nesvategrast (OTT166 5%), its eye drop candidate for diabetic retinopathy, did not meet its primary or key secondary efficacy endpoints in the Phase II...

3/21/2024
ChinaIndiaMeetingMyopiaNewsletter
2024 APAO Congress Brainstorms How to Expand Access to Eye Care; Companies Showcase Tech Boom
2024 APAO Congress Brainstorms How to Expand Access  to Eye Care; Companies Showcase Tech Boom

Nearly 7,800 delegates attended the 2024 congress of the Asia-Pacific Academy of Ophthalmology in southern Bali from Feb. 22-25. The 253 sessions and 120 exhibits spread across four floors in two n...

3/22/2024
BreakingRegulationRetina
Eylea HD, Izervay Get Billing J-Codes in the US
Eylea HD, Izervay Get Billing J-Codes in the US

The Centers for Medicare and Medicaid Services (CMS) has issued J-codes for Regeneron’s Eylea HD and Astellas Pharma’s Izervay. The billing codes take effect April 1, 2024. Eylea HD (aflibercept) i...

3/22/2024
BreakingFundingSurgical
Bascom Palmer Uses $1 Million Gift to Launch Whole Eye Transplant Initiative
Bascom Palmer Uses $1 Million Gift to Launch Whole Eye Transplant Initiative

Bascom Palmer Eye Institute reported March 5 that it would use a $1 million donation to fast-forward its initiative to transplant a whole eye. The hospital, part of the University of Miami, said th...

3/22/2024
BreakingDiagnosticFundraisingRetinaStudy
AI Has Perfect Detection Rate for Severe Cases of ROP in Study
AI Has Perfect Detection Rate for Severe Cases of ROP in Study

Artificial intelligence can accurately and independently detect 100 percent of severe cases of retinopathy of prematurity (ROP), according to a study published March 7 in the journal JAMA Ophthalmo...

3/22/2024
BreakingDry EyeIndustry
Amring Adopts Name Nordic Pharma Amid Ownership Change
Amring Adopts Name Nordic Pharma Amid Ownership Change

Amring Pharmaceuticals announced March 4 that it had changed its name to Nordic Pharma Inc., following the change in ownership of the company from Sever Life Sciences to Nordic Group in June 2023. ...

Provider Surveys & Interviews

Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Table of Innovation

Choose Your Own Adventure

Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.

Safe, Secure & On Any Device

We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.

Pre-Qualified Invitations

We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.

Better Data = Better Decisions

A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.

Market Scope+ App Screen

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

Select your country...